Pylarify
Ended Awarded Last action
- Contract number
- 36C24723N0444
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 7
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $1,890,969
Award facts
- Contract value 50% obligated
-
- $2,670,452.80 Current, with exercised options
- $3,753,068.80 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- New York, NY 10007, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $7,217 | |
| Supplemental Agreement for work within scope | -$25,261 | |
| Supplemental Agreement for work within scope | $108,262 | |
| Exercise an Option | $541,308 | |
| Supplemental Agreement for work within scope | -$1,447,097 | |
| Exercise an Option | $541,308 | |
| Supplemental Agreement for work within scope | $1,623,924 | |
| Original award | $541,308 |
About this award
Veterans Integrated Service Network 7 issued a delivery order to Progenics Pharmaceuticals Inc. on September 1, 2023, for PYLARIFY (piflufolastat F-18) radiopharmaceutical supply, with a ceiling value of $3,753,068.80 and an ultimate completion date of August 31, 2028.
The order is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Place of performance is New York, NY 10007. Progenics Pharmaceuticals, operating as a division of Lantheus Medical Imaging, Inc., supplies PYLARIFY, a radioactive diagnostic imaging agent used in positron emission tomography scans for prostate cancer detection and localization. Pricing is firm fixed price with no set-aside designation.
Quick answers
Who was awarded contract 36C24723N0444?
36C24723N0444 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 7 (Veterans Health Administration) on September 1, 2023.
How much is contract 36C24723N0444 worth?
The government has obligated $1,890,969 on 36C24723N0444. Its current value, with exercised options, is $2,670,453. Its potential value, with all options, is $3,753,069.
Is contract 36C24723N0444 an order under another contract?
Yes. 36C24723N0444 is a delivery order under 36F79719D0170, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24723N0444 competed?
The extent of competition for 36C24723N0444 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award